Medical Communications

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …

Leading UK-based HIV and sexual health charity The Terrence Higgins Trust has announced the appointment of Ian Green as the …

Valeant has named company director Howard Schiller as interim chief executive officer to serve while full-time boss Michael Pearson is …

BioMarin Pharmaceutical has announced the election of former Allergan chief executive, David Pyott, to the company’s board of directors. Pyott served …

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …

What will be the key industry trends in 2016?Pricing pressures

Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …

The Prescription Medicines Code of Practice Authority is investigating Astellas for deliberately providing an ‘incomplete and misleading’ response to a …

The Prime Medical Group has announced the appointment of Valerie Moss PhD to the position of editorial & scientific executive …

The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …

Stirling Anglian, the company at the centre of media criticism for arranging meetings at lavish hotels in an attempt to …

Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …

Valeant has retained attorney Robert Kelner, a partner at the law firm Covington & Burling, to help the beleaguered pharma …

MSD has appointed former Lexington Health boss Jessica Fine to lead its external affairs team in the UK from April …

Avacta Group, the developer of Affimer biotherapeutics and research reagents, has appointed Tony Gardiner as group chief financial officer. Gardiner …